The pyrin inflammasome senses OCTN2-mediated uptake of extracellular ʟ-carnitine from muscle injury or ingestion.

Summary

Using LPS-challenged mice and LPS-primed murine and human macrophages, the study found that extracellular L-carnitine activates the pyrin inflammasome after uptake through the high-affinity transporter OCTN2. L-carnitine suppressed mevalonate synthesis, and pyrin and OCTN2 were also required for inflammatory responses to skeletal muscle injury, establishing a previously unrecognized connection between muscle damage, dietary metabolites, and innate inflammation.

Key Findings

• Extracellular L-carnitine activated the pyrin inflammasome in LPS-challenged mice and LPS-primed murine and human macrophages.
• OCTN2-mediated cellular uptake of L-carnitine and repression of mevalonate synthesis were required for this inflammatory pathway.
• Pyrin and OCTN2 were required for inflammatory responses to skeletal muscle injury, suggesting sensing of muscle-derived L-carnitine as a damage signal.

Clinical Implications

The findings are not yet practice-changing, but they suggest that OCTN2, L-carnitine handling, mevalonate metabolism, or pyrin inflammasome signaling could become targets for future anti-inflammatory interventions. Translation to human sepsis will require confirmation that this pathway contributes to clinically relevant disease phenotypes.

Limitations

• The abstract does not establish whether the pathway is causally important in patients with sepsis or other human inflammatory diseases.
• The translational safety and therapeutic feasibility of modifying L-carnitine transport or pyrin signaling remain unknown.

Future Directions

Future studies should assess this pathway in human sepsis cohorts, determine whether circulating or tissue L-carnitine predicts inflammatory severity, and test selective modulation of OCTN2, mevalonate metabolism, or pyrin signaling in clinically relevant infection and injury models.